Trinidad and Tobago

Trinidad and Tobago

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.51 (0.43 - 0.60) 2019 Modelled IHME
0.52 (0.44 - 0.60) 2018 Modelled IHME
0.53 (0.45 - 0.61) 2017 Modelled IHME
0.54 (0.46 - 0.61) 2016 Modelled IHME
0.54 (0.46 - 0.63) 2015 Modelled IHME
0.54 (0.46 - 0.63) 2014 Modelled IHME
0.55 (0.47 - 0.64) 2013 Modelled IHME
0.56 (0.47 - 0.65) 2012 Modelled IHME
0.57 (0.48 - 0.67) 2011 Modelled IHME
0.58 (0.49 - 0.68) 2010 Modelled IHME
0.59 (0.49 - 0.69) 2009 Modelled IHME
0.6 (0.50 - 0.70) 2008 Modelled IHME
0.61 (0.51 - 0.71) 2007 Modelled IHME
0.62 (0.51 - 0.72) 2006 Modelled IHME
0.63 (0.51 - 0.73) 2005 Modelled IHME
0.63 (0.52 - 0.74) 2004 Modelled IHME
0.63 (0.52 - 0.74) 2003 Modelled IHME
0.63 (0.52 - 0.75) 2002 Modelled IHME
0.64 (0.52 - 0.76) 2001 Modelled IHME
0.64 (0.52 - 0.77) 2000 Modelled IHME
0.64 (0.52 - 0.77) 1999 Modelled IHME
0.65 (0.53 - 0.77) 1998 Modelled IHME
0.66 (0.53 - 0.78) 1997 Modelled IHME
0.66 (0.53 - 0.78) 1996 Modelled IHME
0.66 (0.53 - 0.78) 1995 Modelled IHME
0.66 (0.53 - 0.78) 1994 Modelled IHME
0.66 (0.53 - 0.77) 1993 Modelled IHME
0.65 (0.53 - 0.76) 1992 Modelled IHME
0.64 (0.53 - 0.75) 1991 Modelled IHME
0.63 (0.52 - 0.74) 1990 Modelled IHME
1.26 (0.15 - 9.63) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.06 (0.04 - 0.08) 2019 Modelled IHME
0.06 (0.04 - 0.08) 2018 Modelled IHME
0.06 (0.04 - 0.08) 2017 Modelled IHME
0.06 (0.04 - 0.08) 2016 Modelled IHME
0.06 (0.04 - 0.08) 2015 Modelled IHME
0.06 (0.04 - 0.08) 2014 Modelled IHME
0.06 (0.04 - 0.08) 2013 Modelled IHME
0.07 (0.05 - 0.09) 2012 Modelled IHME
0.07 (0.05 - 0.09) 2011 Modelled IHME
0.07 (0.05 - 0.10) 2010 Modelled IHME
0.08 (0.06 - 0.11) 2009 Modelled IHME
0.09 (0.06 - 0.12) 2008 Modelled IHME
0.1 (0.07 - 0.13) 2007 Modelled IHME
0.11 (0.08 - 0.15) 2006 Modelled IHME
0.12 (0.08 - 0.17) 2005 Modelled IHME
0.15 (0.11 - 0.21) 2004 Modelled IHME
0.2 (0.14 - 0.28) 2003 Modelled IHME
0.25 (0.17 - 0.35) 2002 Modelled IHME
0.3 (0.20 - 0.41) 2001 Modelled IHME
0.32 (0.22 - 0.44) 2000 Modelled IHME
0.33 (0.22 - 0.45) 1999 Modelled IHME
0.34 (0.23 - 0.45) 1998 Modelled IHME
0.34 (0.23 - 0.46) 1997 Modelled IHME
0.34 (0.23 - 0.47) 1996 Modelled IHME
0.34 (0.23 - 0.47) 1995 Modelled IHME
0.34 (0.24 - 0.47) 1994 Modelled IHME
0.34 (0.24 - 0.46) 1993 Modelled IHME
0.34 (0.24 - 0.46) 1992 Modelled IHME
0.34 (0.24 - 0.46) 1991 Modelled IHME
0.34 (0.24 - 0.45) 1990 Modelled IHME
0.43 (0.05 - 3.53) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.89 (1.29 - 2.66) 2019 Modelled IHME
1.88 (1.25 - 2.62) 2018 Modelled IHME
1.86 (1.25 - 2.58) 2017 Modelled IHME
1.83 (1.26 - 2.56) 2016 Modelled IHME
1.8 (1.25 - 2.53) 2015 Modelled IHME
1.82 (1.30 - 2.49) 2014 Modelled IHME
1.9 (1.42 - 2.51) 2013 Modelled IHME
1.98 (1.54 - 2.52) 2012 Modelled IHME
2.14 (1.65 - 2.71) 2011 Modelled IHME
2.21 (1.72 - 2.81) 2010 Modelled IHME
2.23 (1.75 - 2.82) 2009 Modelled IHME
2.31 (1.80 - 2.93) 2008 Modelled IHME
2.15 (1.68 - 2.71) 2007 Modelled IHME
2.12 (1.66 - 2.66) 2006 Modelled IHME
2.17 (1.68 - 2.76) 2005 Modelled IHME
2.15 (1.70 - 2.72) 2004 Modelled IHME
2.13 (1.68 - 2.67) 2003 Modelled IHME
2.09 (1.66 - 2.63) 2002 Modelled IHME
2.11 (1.67 - 2.63) 2001 Modelled IHME
2.05 (1.61 - 2.56) 2000 Modelled IHME
2.26 (1.79 - 2.80) 1999 Modelled IHME
2.57 (2.07 - 3.13) 1998 Modelled IHME
2.62 (2.12 - 3.17) 1997 Modelled IHME
2.93 (2.39 - 3.55) 1996 Modelled IHME
2.93 (2.41 - 3.53) 1995 Modelled IHME
3.16 (2.60 - 3.83) 1994 Modelled IHME
3.21 (2.62 - 3.89) 1993 Modelled IHME
3.17 (2.58 - 3.85) 1992 Modelled IHME
3.21 (2.65 - 3.87) 1991 Modelled IHME
3.32 (2.73 - 3.97) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
26 (18 - 37) 2019 Modelled IHME
26 (17 - 36) 2018 Modelled IHME
26 (17 - 36) 2017 Modelled IHME
25 (17 - 35) 2016 Modelled IHME
25 (17 - 35) 2015 Modelled IHME
25 (18 - 34) 2014 Modelled IHME
26 (19 - 34) 2013 Modelled IHME
27 (21 - 34) 2012 Modelled IHME
29 (22 - 37) 2011 Modelled IHME
30 (23 - 38) 2010 Modelled IHME
30 (23 - 38) 2009 Modelled IHME
31 (24 - 39) 2008 Modelled IHME
29 (22 - 36) 2007 Modelled IHME
28 (22 - 35) 2006 Modelled IHME
29 (22 - 37) 2005 Modelled IHME
28 (22 - 36) 2004 Modelled IHME
28 (22 - 35) 2003 Modelled IHME
27 (22 - 34) 2002 Modelled IHME
27 (22 - 34) 2001 Modelled IHME
27 (21 - 33) 2000 Modelled IHME
29 (23 - 36) 1999 Modelled IHME
33 (26 - 40) 1998 Modelled IHME
33 (27 - 40) 1997 Modelled IHME
37 (30 - 45) 1996 Modelled IHME
37 (30 - 44) 1995 Modelled IHME
39 (32 - 48) 1994 Modelled IHME
40 (32 - 48) 1993 Modelled IHME
39 (32 - 47) 1992 Modelled IHME
39 (32 - 47) 1991 Modelled IHME
40 (33 - 48) 1990 Modelled IHME
68 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
25 (18 - 34) 2019 Modelled IHME
25 (18 - 33) 2018 Modelled IHME
25 (18 - 33) 2017 Modelled IHME
25 (18 - 34) 2016 Modelled IHME
25 (19 - 34) 2015 Modelled IHME
26 (19 - 34) 2014 Modelled IHME
26 (19 - 35) 2013 Modelled IHME
27 (20 - 35) 2012 Modelled IHME
27 (21 - 36) 2011 Modelled IHME
28 (21 - 36) 2010 Modelled IHME
28 (21 - 36) 2009 Modelled IHME
28 (21 - 36) 2008 Modelled IHME
28 (21 - 36) 2007 Modelled IHME
28 (21 - 36) 2006 Modelled IHME
28 (21 - 36) 2005 Modelled IHME
28 (21 - 36) 2004 Modelled IHME
28 (21 - 36) 2003 Modelled IHME
28 (21 - 36) 2002 Modelled IHME
28 (21 - 37) 2001 Modelled IHME
28 (21 - 37) 2000 Modelled IHME
28 (21 - 37) 1999 Modelled IHME
28 (21 - 37) 1998 Modelled IHME
29 (21 - 37) 1997 Modelled IHME
29 (21 - 37) 1996 Modelled IHME
28 (21 - 37) 1995 Modelled IHME
28 (21 - 37) 1994 Modelled IHME
28 (21 - 37) 1993 Modelled IHME
28 (21 - 37) 1992 Modelled IHME
28 (21 - 37) 1991 Modelled IHME
28 (21 - 37) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
89 2017 Survey/reported WHO/UNICEF
97 2016 Survey/reported WHO/UNICEF
90 2015 Survey/reported WHO/UNICEF
92 2014 Survey/reported WHO/UNICEF
92 2013 Survey/reported WHO/UNICEF
92 2012 Survey/reported WHO/UNICEF
90 2011 Survey/reported WHO/UNICEF
90 2010 Survey/reported WHO/UNICEF
90 2009 Survey/reported WHO/UNICEF
90 2008 Survey/reported WHO/UNICEF
89 2007 Survey/reported WHO/UNICEF
89 2006 Survey/reported WHO/UNICEF
95 2005 Survey/reported WHO/UNICEF
94 2004 Survey/reported WHO/UNICEF
76 2003 Survey/reported WHO/UNICEF
5 2002 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV elimination goal
HBV National Action Plan
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
No
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.68 (1.35 - 2.08) 2019 Modelled IHME
1.66 (1.35 - 2.07) 2018 Modelled IHME
1.65 (1.34 - 2.06) 2017 Modelled IHME
1.63 (1.33 - 2) 2016 Modelled IHME
1.61 (1.31 - 1.98) 2015 Modelled IHME
1.6 (1.31 - 1.97) 2014 Modelled IHME
1.6 (1.30 - 1.97) 2013 Modelled IHME
1.59 (1.29 - 1.98) 2012 Modelled IHME
1.59 (1.29 - 1.98) 2011 Modelled IHME
1.59 (1.29 - 1.99) 2010 Modelled IHME
1.59 (1.29 - 1.99) 2009 Modelled IHME
1.59 (1.29 - 1.98) 2008 Modelled IHME
1.6 (1.30 - 1.98) 2007 Modelled IHME
1.6 (1.30 - 1.98) 2006 Modelled IHME
1.6 (1.30 - 1.98) 2005 Modelled IHME
1.6 (1.30 - 1.98) 2004 Modelled IHME
1.6 (1.30 - 1.98) 2003 Modelled IHME
1.6 (1.31 - 1.99) 2002 Modelled IHME
1.6 (1.30 - 1.99) 2001 Modelled IHME
1.6 (1.31 - 1.99) 2000 Modelled IHME
1.61 (1.32 - 2) 1999 Modelled IHME
1.63 (1.33 - 2.03) 1998 Modelled IHME
1.66 (1.36 - 2.06) 1997 Modelled IHME
1.69 (1.38 - 2.10) 1996 Modelled IHME
1.71 (1.39 - 2.13) 1995 Modelled IHME
1.72 (1.39 - 2.14) 1994 Modelled IHME
1.73 (1.40 - 2.14) 1993 Modelled IHME
1.74 (1.40 - 2.15) 1992 Modelled IHME
1.75 (1.40 - 2.17) 1991 Modelled IHME
1.75 (1.40 - 2.17) 1990 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.33 (2.28 - 4.77) 2019 Modelled IHME
3.26 (2.22 - 4.72) 2018 Modelled IHME
3.19 (2.21 - 4.50) 2017 Modelled IHME
3.11 (2.15 - 4.39) 2016 Modelled IHME
3 (2.09 - 4.21) 2015 Modelled IHME
2.89 (2.12 - 3.97) 2014 Modelled IHME
2.78 (2.11 - 3.69) 2013 Modelled IHME
2.66 (2.07 - 3.43) 2012 Modelled IHME
2.69 (2.08 - 3.48) 2011 Modelled IHME
2.73 (2.13 - 3.53) 2010 Modelled IHME
2.77 (2.18 - 3.56) 2009 Modelled IHME
2.9 (2.25 - 3.74) 2008 Modelled IHME
2.7 (2.11 - 3.46) 2007 Modelled IHME
2.67 (2.07 - 3.44) 2006 Modelled IHME
2.74 (2.12 - 3.54) 2005 Modelled IHME
2.74 (2.11 - 3.53) 2004 Modelled IHME
2.7 (2.10 - 3.47) 2003 Modelled IHME
2.64 (2.05 - 3.38) 2002 Modelled IHME
2.68 (2.09 - 3.48) 2001 Modelled IHME
2.59 (2.03 - 3.31) 2000 Modelled IHME
2.81 (2.22 - 3.57) 1999 Modelled IHME
3.03 (2.42 - 3.83) 1998 Modelled IHME
2.99 (2.38 - 3.75) 1997 Modelled IHME
3.27 (2.63 - 4.08) 1996 Modelled IHME
3.25 (2.62 - 4.04) 1995 Modelled IHME
3.51 (2.81 - 4.36) 1994 Modelled IHME
3.54 (2.85 - 4.40) 1993 Modelled IHME
3.49 (2.81 - 4.32) 1992 Modelled IHME
3.51 (2.82 - 4.34) 1991 Modelled IHME
3.65 (2.94 - 4.49) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
46 (32 - 66) 2019 Modelled IHME
45 (31 - 65) 2018 Modelled IHME
44 (31 - 62) 2017 Modelled IHME
43 (30 - 61) 2016 Modelled IHME
41 (29 - 58) 2015 Modelled IHME
40 (29 - 54) 2014 Modelled IHME
38 (29 - 50) 2013 Modelled IHME
36 (28 - 47) 2012 Modelled IHME
36 (28 - 47) 2011 Modelled IHME
37 (29 - 48) 2010 Modelled IHME
37 (29 - 48) 2009 Modelled IHME
39 (30 - 50) 2008 Modelled IHME
36 (28 - 46) 2007 Modelled IHME
35 (27 - 46) 2006 Modelled IHME
36 (28 - 47) 2005 Modelled IHME
36 (28 - 47) 2004 Modelled IHME
35 (28 - 45) 2003 Modelled IHME
34 (27 - 44) 2002 Modelled IHME
35 (27 - 45) 2001 Modelled IHME
34 (26 - 43) 2000 Modelled IHME
36 (29 - 46) 1999 Modelled IHME
39 (31 - 49) 1998 Modelled IHME
38 (30 - 48) 1997 Modelled IHME
41 (33 - 51) 1996 Modelled IHME
41 (33 - 51) 1995 Modelled IHME
44 (35 - 54) 1994 Modelled IHME
44 (35 - 54) 1993 Modelled IHME
43 (34 - 53) 1992 Modelled IHME
43 (34 - 53) 1991 Modelled IHME
44 (35 - 54) 1990 Modelled IHME
29 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
23 (16 - 31) 2019 Modelled IHME
23 (16 - 31) 2018 Modelled IHME
23 (17 - 31) 2017 Modelled IHME
23 (17 - 31) 2016 Modelled IHME
23 (16 - 31) 2015 Modelled IHME
23 (17 - 31) 2014 Modelled IHME
23 (17 - 30) 2013 Modelled IHME
23 (16 - 30) 2012 Modelled IHME
23 (16 - 30) 2011 Modelled IHME
23 (16 - 30) 2010 Modelled IHME
23 (16 - 30) 2009 Modelled IHME
23 (16 - 30) 2008 Modelled IHME
23 (16 - 30) 2007 Modelled IHME
23 (16 - 31) 2006 Modelled IHME
23 (16 - 30) 2005 Modelled IHME
23 (16 - 31) 2004 Modelled IHME
23 (16 - 30) 2003 Modelled IHME
23 (16 - 31) 2002 Modelled IHME
23 (16 - 31) 2001 Modelled IHME
24 (17 - 31) 2000 Modelled IHME
23 (16 - 31) 1999 Modelled IHME
23 (16 - 30) 1998 Modelled IHME
23 (16 - 30) 1997 Modelled IHME
23 (16 - 31) 1996 Modelled IHME
23 (16 - 31) 1995 Modelled IHME
24 (17 - 31) 1994 Modelled IHME
23 (16 - 31) 1993 Modelled IHME
24 (17 - 31) 1992 Modelled IHME
24 (16 - 31) 1991 Modelled IHME
23 (16 - 31) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV elimination goal
HBV National Action Plan
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
No
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
26
2019
(18 - 37)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
46
2019
(32 - 66)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines